Consent Forms. Facility User shall obtain a consent and waiver of liability form for each minor attending the Event, which authorizes Facility User’s employees or staff to take ill or injured attendees for medical treatment. Forms shall be signed by the parent or legal guardian of any minor attending the Event. Completed forms shall be retained by Facility User and made available to University upon request.
Consent Forms. Provide the Reviewing IRB with the site-specific information requested/identified in the customizable sections of the Reviewing IRB’s consent form, for review and approval by the Reviewing IRB, when written informed consent is required. Once the consent form is approved for use by the Relying Institution/Site Investigator(s), the Relying Institution will not, and will require that its Site Investigator(s) not, make any change to the form without obtaining prior approval of that change from the Reviewing IRB.
Consent Forms. Provide to each Relying Institution and Site Investigator(s) informed consent forms to use for the Research where the Reviewing IRB has determined that such a consent form(s) is required. The Reviewing IRB will permit a Relying Institution/Site Investigator(s) to customize limited site-specific sections of the form, generally the sections on the availability of treatment and compensation for research-related injury; payment or reimbursement of research costs incurred by subjects; and local contacts. Any such modifications will be subject to approval by the Reviewing IRB, which will then provide a final approved consent form(s) to the Relying Institution(s)/Site Investigator(s) for use.
Consent Forms. As directed by Practice, complete the clerical aspects necessary for preparing client consent forms; provided, however, that the content of such forms shall be determined by Practice, and provided, further, that the communication of clinical information to clients shall solely be the responsibility of Practice and the Licensed Contractors;
Consent Forms. OV shall prepare the patient informed consent form for the mBC Clinical Trial in consultation with R-Pharm. Any changes to such model form that relate to the Product shall be subject to R-Pharm’s written consent, not to be unreasonably withheld, conditioned, or delayed. R-Pharm will provide such consent, or a written explanation for why such consent is being withheld, within fifteen (15) Business Days after receiving OV’s request therefor. OV shall obtain all patient authorizations and consents for the mBC Clinical Trial, and OV shall ensure that all patient authorizations and consents in connection with the mBC Clinical Trial permit, in accordance with HIPAA, the EU Data Protection Directive or any other similar Applicable Law, sharing of mBC Clinical Trial Data with R-Pharm in accordance with this Agreement.
Consent Forms. Provide to each Relying Institution and Site Investigator(s) informed consent forms to use for the Research where the Reviewing IRB has determined that such a consent form(s) is required. The Reviewing IRB will permit a Relying Institution/Site Investigator(s) to customize limited site-specific sections of the form, generally the sections on the availability of treatment and compensation for research-related injury; payment or reimbursement of research costs incurred by subjects; and local contacts. Any such modifications will be subject to approval by the Reviewing IRB, which will then provide a final approved consent form(s) to the Relying Institution(s)/Site Investigator(s) for use. Conflicts of Interest. Consider any applicable conflict of interest assurances received from federal Relying Institutions or conflict of interest determinations and associated management plans provided by non-federal Relying Institutions pursuant to Section 6.6 hereof with respect to the Overall PI, Site Investigator(s), and other Research Personnel in connection with the Research. The Reviewing IRB will ensure that any management plan is incorporated into its initial or continuing review or other deliberations, as applicable, and without limiting the foregoing, that any disclosures to subjects required by the plan and that are approvable by the Reviewing IRB are included in the approved informed consent form(s) for the relevant Relying Institution. The Reviewing IRB retains the authority to impose additional prohibitions or conflict management requirements more stringent or restrictive than proposed by a non-federal Relying Institution if necessary to approve the Research, provided, however, the Reviewing IRB will not modify or change any management plan or mandated disclosure to subjects without discussion with and acceptance by the Relying Institution. In the extraordinary circumstance that the Reviewing IRB is unable to implement/approve a non-federal Relying Institution’s prohibitions or management plans, the Reviewing IRB will so inform such Relying Institution or, if the non-federal Relying Institution fails to accept any additional prohibitions or requirements, the non-federal Relying Institution will so inform the Reviewing IRB. If the institutions are not able to identify a mutually agreeable approach, the Research will be withdrawn from Ceded Review (without an IRB approval or disapproval) with respect to that non-federal Relying Institution. If the Reviewing IRB ...
Consent Forms. ☐MH Specific consent/assent form(s) [approved model consent from the IRB of Record] tracked with the MH local context information (See Appendix A or B. The ICF will need to be reviewed by the IRB PRIOR to sending to the sponsor for approval to ensure required language is present.
Consent Forms. Provide to each Relying Institution and Site Investigator(s) informed consent forms to use for the Research where the Reviewing IACUC has determined that such a consent form(s) is required. The Reviewing IACUC will permit a Relying Institution/Site Investigator(s) to customize limited site-specific sections of the form, generally the sections on the availability of treatment and compensation for research-related adverse events; payment or reimbursement of research costs incurred; and local contacts. Any such modifications will be subject to approval by the Reviewing IACUC, which will then provide a final approved consent form(s) to the Relying Institution(s)/Site Investigator(s) for use.
Consent Forms. Provide the Reviewing IACUC with the site-specific information requested/identified in the customizable sections of the Reviewing IACUC’s consent form, for review and approval by the Reviewing IACUC, when written informed consent is required. Once the consent form is approved for use by the Relying Institution/Site Investigator(s), the Relying Institution will not, and will require that its Site Investigator(s) not, make any change to the form without obtaining prior approval of that change from the Reviewing IACUC.
Consent Forms. With respect to Research requiring documentation of consent, a Reviewing IRB will Pprovide or distribute to each the Relying Institution(s) and Site Investigator(s) or other Personnel informed consent forms or broad consent forms (as applicable under Federal Policy) to use for the Research where the Reviewing IRB has determined that such a consent form(s) is required. The Reviewing IRB will permit athe Relying Institution(s)/Site Investigator(s)/other Personnel to customize limited site-specific sections of the form(s), generally the sections on the availability of treatment and compensation for research-related injury; payment or reimbursement of research costs incurred by subjects and local contacts and will consider requests from the Relying Institution(s) on other sections of the form(s) if necessary to address legal or regulatory issues or federal department- or agency-specific requirements. Any such modificationscustomizations or requests will be subject to approval by the Reviewing IRB, which will then provide athe final approved consent form(s) to the Relying Institution(s)/Site Investigator(s)/other Personnel for use.
